June 11th 2015
Auditori Antoni Caparrós, Torre D, Barcelona Science Park
Baldiri Reixac, 4 - 08028 Barcelona
Many scientists follow a career in research without considering alternatives. This course of action often ends up being unsatisfactory, as it leads them to take up unsuitable jobs or to abandon science altogether. This session will provide researchers at any point in their careers with the opportuniy to look beyond the bench and to discover new and exciting career options.
9.15 - 9.30 h - Registration
9.30 - 10.30 h - Speaker introductions
10.30 – 10.45 – General questions
10.45 - 12.00 h - Informal discussion and mid-morning snack
- Raül Insa, CEO, SOM Biotech
- Rosina Malagrida, Head of Public Engagement on Health Research, Institut de Recerca de la Sida IrsiCaixa
- Goretti Mallorquí, Scientific Officer, Research and Academic Administration Department, IRB Barcelona
- Dominique Monferrer, Regulatory Affairs Manager at Asphalion
- Marusela Oliveras, Junior Business Development Manager, Erasmus MC
- Markus Wilhelms, CEO and Co-founder of usMIMA
- Jordi Quintana, Head of Business Development, Director of Drug Discovery Platform, PCB
| ||Raül Insa, CEO, SOM Biotech |
Raúl Insa, MD, PhD, MBA, is the CEO and Founder of SOM Biotech, a start-up biopharmaceutical company established in the Barcelona Scientific Park and specialized in drug repositioning through an in-silico solution. Previously, he has been working for more than 20 years in multinational pharmaceutical companies, such as Parke-Davis (now Pfizer), UCB Pharma, Uriach Group (now Palau Pharma) and ISDIN (from Esteve Group). Raúl received his Medical training and his PhD in Clinical Neurology at the University of Alicante, Spain; an MBA from ESADE Business School in Barcelona and an Executive Education Program from IESE, Barcelona. He has also attended a couple of biotech leadership programs from Harvard Business School, Boston. He has been involved in the foundation of at least five companies, three of them still alive.
| || |
Rosina Malagrida, Head of Public Engagement on Health Research, Institut de Recerca de la Sida IrsiCaixa
Rosina Malagrida has a degree in chemistry from the University of Barcelona, Spain, and a master’s in science communication from Imperial College London, UK. She is specialised in public engagement and non-formal education activities, mainly on health research. Currently, she is the head of Public Engagement on Health Research at IrsiCaixa in Barcelona, where she co-ordinates the European educational portal Xplore Health, and a programme for outreach and prevention on AIDS. She is also the deputy coordinator of the EC project RRI tools, to promote Responsible Research and Innovation in Europe. Rosina previously worked at the Barcelona Science Park and at the science museums of London and Barcelona, developing exhibitions, experimental workshops, fairs and debates to decrease the gap between research and society.
| || |
Goretti Mallorquí, Scientific Officer, Research and Academic Administration Department, IRB Barcelona
Goretti holds a BsC degree in Biology by the University of Girona (1998), a MSc in Biotechnology (2000) and a PhD in Biochemistry from the same University (2003). After her first postdoc at the IBMB-CSIC, she moved to New York to carry out a postdoc at the Hospital for Special Surgery (2007). She came back in 2009 as a senior scientist in protein purification at ERA Biotech while completing a Masters degree in Science Communication (Universitat Pompeu Fabra). She left for Seville in 2012 to join Abengoa Bioenergies and she was back in Barcelona in 2013 to work as project manager in the UPF. She is at IRB Barcelona since April 2014.
| || Dominique Monferrer, Regulatory Affairs Manager at Asphalion |
Dominique studied Human Biology at the University Pompeu Fabra (2004) and obtained a PhD in Structural Biology by the University of Barcelona (2009) under the supervision of Prof. Usón. After six years of basic research in X-Ray Crystallography at the IBMB-CSIC she followed a postgraduate course in Innovation Management organized by the Fundació Bosch i Gimpera (2010), and started working at Asphalion, a consultancy in Regulatory Affairs, where she assesses in development, registration and maintenance of chemical drugs, biologics and medical devices to pharmaceutical and medtech companies.
Marusela Oliveras, Junior Business Development Manager, Erasmus MC
Marusela holds a MSc degree in Medical Biology by the University of Barcelona (2009) and a PhD in Biomedical Sciences by the K.U. Leuven in Belgium (2013). Under the framework of a Marie Curie ITN fellowship, her doctoral thesis consisted on the development of new mouse models for Parkinson’s disease. After her promotion, she came back to Barcelona where she worked as a Technology Transfer Officer at IRB Barcelona. More recently, she moved to the Netherlands and was recruited by Erasmus Medical Centre, the largest medical center of the Netherlands. There, she works as a Jr. Business Development Manager at the Technology Transfer Office.
Markus Wilhelms, CEO and Co-founder of usMIMA
Markus has studies Biology at the University of Hannover and the Berlin Humboldt Univesity in Germany and obtained a PhD in Molecular Microbiology at the University of Barcelona.
After 2 years as postdoctoral researcher he enlisted in the MOEBIO dHEALTH Barcelona postgraduate program to learn about innovation and entrepreneurship in healthcare.
In late 2014 he co-founded the healthcare startup usMIMA with 3 other dHEALTH fellows where he holds the position of CEO.
usMIMA is developing a non-pharma, no-invasive, no-side-effect solution to chronic constipation and just recently closed their seed investment round.
As winner of the 7th edition of the BioEmprendedorXXI award, usMIMA has been voted the most promising StartUp of the bio/healthcare sector in Catalunya/Spain for 2014.
Jordi Quintana, Head of Business Development, Director of Drug Discovery Platform, PCB
Jordi holds a BsC degree in Chemistry from Institut Químic de Sarrià (IQS, Barcelona, 1984). After 2,5 years working as a Research Chemist at a polymer chemistry company, he moved to the USA to obtain a Ph.D. in Biochemistry at the University of California, Los Angeles (UCLA, 1991). After two short postdoctoral stays at UCLA (1991-1992) and at Universitat Politècnica de Catalunya, UPC (1992-1993), he joined the R+D Area at Esteve, a leading pharmaceutical company based in Barcelona, where he built and expanded the Drug Design Department (1993-2007), and acted as Project Manager in several R+D initiatives at Esteve. In 2007, Jordi joined Parc Científic de Barcelona (PCB), to start the Drug Discovery Platform and the Spanish Chemical Biology initiative, Chembiobank. His responsibilities at PCB also include the Business Development area.